Advances in medicine & biology. Volume 46 /
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Hauppauge, N.Y. :
Nova Science,
©2012.
|
Colección: | Advances in Medicine and Biology.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- ""ADVANCES IN MEDICINE AND BIOLOGY VOLUME 46 ""; ""ADVANCES IN MEDICINE AND BIOLOGY VOLUME 46 ""; ""CONTENTS ""; ""PREFACE ""; ""SEXUAL DIMORPHISM IN CORTICOSTEROID SIGNALING � UNDERNEATH VULNERABILITY TO STRESS-RELATED DISORDERS AND SENSITIVITY TO ANTIDEPRESSANTS ""; ""ABSTRACT ""; ""INTRODUCTION ""; ""HOW DOES CORTICOSTEROID RECEPTORS PROTEIN LEVEL DIFFER BETWEEN GENDERS? ""; ""Influence of Stress ""; ""Response to Antidepressant Drugs ""; ""THE IMPORTANCE OF THE CORTICOSTEROID RECEPTOR HORMONE-BINDING CAPACITY � UNDER THE SPOTLIGHT ""; ""The MR/GR Ratio ""; ""The Binding Potency ""
- ""DO ANTIDEPRESSANTS COOPERATE WITH THE RECEPTOR�S CHAPERONES? """"THE RECEPTOR�S BINDING TO THE NUCLEI AND DNA ""; ""GENDER DIFFERENCES IN THE ANTIDEPRESSANT DRUG METABOLISM""; ""OTHER MECHANISMS CONTRIBUTING TO SEXUALLY DIMORPHIC RESPONSE TO STRESS AND TO ANTIDEPRESSANT DRUGS ""; ""The Hormone Availability ""; ""Transport through Membrane ""; ""CONCLUDING REMARKS AND FUTURE PERSPECTIVES""; ""REFERENCES ""; ""CELL MATRIX INTERACTIONS AND ROLE OF INTEGRINS IN LIVER DEVELOPMENT ""; ""INTRODUCTION ""; ""1. FOCAL ADHESIONS ""; ""1.1. Composition of Focal Adhesions ""
- ""1.1.1. Tyrosine Phosphorylation at Focal Adhesions""""1.1.2. Adaptor Proteins/ Binding Proteins ""; ""1.2. Regulation of Focal Adhesions ""; ""2. LIVER DEVELOPMENT ""; ""2.1. Hepatic Endoderm Specification ""; ""2.2. Formation of the Hepatic Bud `from Hepatic Endoderm ""; ""2.2.1. Proliferation and Migration ""; ""2.2.2. Liver Bud Growth ""; ""2.3. Hepatocyte Specification ""; ""2.4. Hepatocyte Maturation ""; ""3. LIVER ARCHITECTURE ""; ""4. DISRUPTED LIVER ARCHITECTURE ""; ""4.1. Fibrosis""; ""4.2. Integrins and Liver Disease""; ""CONCLUSIONS ""; ""ACKNOWLEDGMENTS ""; ""REFERENCES ""
- ""HEPATIC ENCEPHALOPATHY """"ABSTRACT ""; ""INTRODUCTION ""; ""CLINICAL DEFINITION OF HE ""; ""CLINICAL SCALES FOR HE GRADING ""; ""A) Scaling System ""; ""B) Neuropsychometric Tests ""; ""C) Critical Flicker Frequency (CFF) Test [13, 14] ""; ""PROGNOSIS OF HE""; ""PATHOGENESIS""; ""AMMONIA AND ITS METABOLITES ""; ""ROLE OF GLUTAMINE ""; ""MANGANESE ""; ""GABA HYPOTHESIS ""; ""NEUROSTEROIDS ""; ""INFLAMMATION ""; ""OXIDATIVE STRESS ""; ""TREATMENT ""; ""1. Nutritional Management ""; ""Branched-Chain Amino Acids ""; ""Implementation ""; ""Acute Encephalopathy ""
- ""2. Reduction in the Nitrogenous Load Arising From the Gut """"A) Bowel Cleansing ""; ""Implementation ""; ""B) Nonabsorbable Disaccharides ""; ""Implementation ""; ""C) Antibiotics ""; ""Implementation ""; ""D) Acceleration of Urea Cycle ""; ""3. Drugs that Affect Neurotransmission ""; ""A) Dopaminergic System""; ""B) GABA-benzodiazepine System ""; ""Implementation ""; ""CONCLUSION ""; ""REFERENCES ""; ""BASIC GUIDELINES FOR THE COLLECTION AND SUBMISSION OF NECROPSY SAMPLES ""; ""ABSTRACT ""; ""INTRODUCTION""; ""EQUIPMENT ""; ""SAFETY PRECAUTIONS ""; ""NECROPSY REQUISITION FORM ""